Are you Dr. Lieberman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6565 Fannin Street
MS205
Houston, TX 77030Phone+1 713-394-6450Fax+1 713-793-1603
Summary
- Dr. Michael Lieberman, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Houston Methodist Hospital.
Education & Training
UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 1967 - 1969
University of Pittsburgh School of MedicineClass of 1967
Certifications & Licensure
TX State Medical License 1989 - 2014- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 34 citationsGlutathione is essential for early embryogenesis - Analysis of a glutathione synthetase knockout mouseAndreas Winkler, Runa Njålsson, Katarina Carlsson, Abdelaziz Elgadi, Björn Rozell
Biochemical and Biophysical Research Communications. 2011-08-19 - 173 citationsSystem xc− and Thioredoxin Reductase 1 Cooperatively Rescue Glutathione DeficiencyPankaj Mandal, Alexander Seiler, Tamara Perisic, Pirkko Kölle, Ana Banjac Canak
The Journal of Biological Chemistry. 2010-07-16 - 55 citationsOLA1, an Obg-like ATPase, suppresses antioxidant response via nontranscriptional mechanisms.Jiawei Zhang, Valentina Rubio, Michael W. Lieberman, Zheng Zheng Shi
Proceedings of the National Academy of Sciences of the United States of America. 2009-09-08
Grant Support
- As-Gsh Conjugation Limits As Availability &ToxicityNational Institute Of Environmental Health Sciences2000–2004
- Baylor College Of Medicine Cancer CenterNational Cancer Institute2003
- Function Of Gamma Glutamyl LeukotrienaseNational Institute Of Environmental Health Sciences2001–2003
- Response To Injury In Gammaglutamyl Cycle Deficient MiceNational Institute Of Environmental Health Sciences2000–2003
- Metabolism In Gamma-Glutamy1 Transpeptidase Defict MiceNational Institute Of Environmental Health Sciences1997–2000
- Responses To Injury In Gamma Glutamyl Cycle DeficientNational Institute Of Environmental Health Sciences1997–1999
- Metabolism In And-Glutamyl Transpeptidase Deficient MiceNational Institute Of Environmental Health Sciences1996
- Consequences Of Targetet Gene Expression To The ProstateNational Cancer Institute1992–1995
- Carcinogen Activation Of Unexpressed Mammalian GenesNational Cancer Institute1989–1995
- Carcinogen Activation Of Unexpressed GenesNational Cancer Institute1994
- Molecular Pathology Of Transgenic Liver &Kidney CancerNational Cancer Institute1991–1993
- Molecular Mechanisms Of Carcinogenesis ConferenceNational Cancer Institute1991
- Metallothionein Activation--A Model Of Carcinogen ActionNational Cancer Institute1989–1991
- Gene Expression In Carcinogen-Induced Liver CancerNational Cancer Institute1989–1990
- Analysis Of Hepatocellular Carcinoma Development By NMR ImagingNational Cancer Institute1987–1989
- Carcinogen Activation Of Unexpressed Mammalian GenesNational Cancer Institute1988
- Gene Expression In Carcinogen-Induced Liver CancerNational Cancer Institute1985–1988
- Carcinogen Activation Of Unexpressed Mammalian GenesNational Cancer Institute1985–1987
